Skip to Main Content
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Effect of Bupropion on Smoking Behavior in Smokers With Schizophrenia
This study has been completed.
Study NCT00218231 Information provided by National Institute on Drug Abuse (NIDA)
First Received: September 16, 2005 Last Updated: August 19, 2008
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Schizophrenia
Tobacco Use Disorder
More general conditions related to this trial
Disorders of Environmental Origin
Mental Disorders
Schizophrenia and Disorders with Psychotic Features
Substance-Related Disorders
Interventions listed in this trial
300 mg/day bupropion-sr
0 mg/day bupropion-sr
Additional drug interventions recognized in this trial
Bupropion
More general drug interventions related to this trial
Antidepressive Agents
Antidepressive Agents, Second-Generation
Central Nervous System Agents
Dopamine Agents
Dopamine Uptake Inhibitors
Molecular Mechanisms of Pharmacological Action
Neurotransmitter Agents
Neurotransmitter Uptake Inhibitors
Pharmacologic Actions
Physiological Effects of Drugs
Psychotropic Drugs
Therapeutic Uses
Sponsors listed in this trial
National Institute on Drug Abuse (NIDA)
Back to top of Main Content
